2017
DOI: 10.1007/s00198-017-4156-3
|View full text |Cite
|
Sign up to set email alerts
|

Strontium ranelate stimulates trabecular bone formation in a rat tibial bone defect healing process

Abstract: SrRan affects bone formation differently in normal mature bone or in the bone healing process. Despite this selective action, this led to similar increased bone volume in both compartments without deleterious effects on the newly bone-formed quality.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(18 citation statements)
references
References 47 publications
0
17
0
1
Order By: Relevance
“…First, they may be due to the short treatment period of 2 or 3 weeks, which for such a complicated model is not long enough to exhibit effects sufficient to convert the molecular benefits into radiological and histologic changes [ 55 ]. Second, while the SR dosage of 600 mg/kg/d in the present study can lead to a blood strontium concentration close to the human therapeutic exposure [ 22 ], this is a relatively lower dosage when considering the 450–900 mg/kg used in previous studies, where it displayed positive effects on bone formation in bone-defect and fracture models [ 22 , 56 62 ]. Further study is needed to determine whether a higher SR dose would exhibit a significant effect on fracture healing in the model of combined estrogen deficiency and diabetes.…”
Section: Discussionmentioning
confidence: 99%
“…First, they may be due to the short treatment period of 2 or 3 weeks, which for such a complicated model is not long enough to exhibit effects sufficient to convert the molecular benefits into radiological and histologic changes [ 55 ]. Second, while the SR dosage of 600 mg/kg/d in the present study can lead to a blood strontium concentration close to the human therapeutic exposure [ 22 ], this is a relatively lower dosage when considering the 450–900 mg/kg used in previous studies, where it displayed positive effects on bone formation in bone-defect and fracture models [ 22 , 56 62 ]. Further study is needed to determine whether a higher SR dose would exhibit a significant effect on fracture healing in the model of combined estrogen deficiency and diabetes.…”
Section: Discussionmentioning
confidence: 99%
“…88 Since it has outstanding properties for bone tissue engineering, various authors decided to evaluate the effects of this compound (Fig. 4): a SR therapy was investigated to assess its effects on fracture frequency and bone mass and strength in mice; 89 a SR treatment was examined in a postmenopausal woman with osteonecrosis of the jaw after long-term oral bisphosphonate administration; 90 SR in the repair of standardized intrabuccal bone defects in Lewis rats was evaluated; 91 the effects of insulin and SR on guided bone regeneration in diabetic Wistar rats were analysed; 92 how a previous biophosphonate treatment can modify the effects of SR on bone mineral density was investigated in humans; 93 the properties of SR for the stimulation of trabecular bone formation in a Sprague-Dawley rat tibial bone defect healing process; 94 the effects of SR on spinal interbody fusion surgery in an osteoporotic Sprague-Dawley rat; 95 and finally, how SR causes osteophyte overgrowth in a model of early phase osteoarthritis in Dunkin Hartley albino guinea pigs. 96…”
Section: Strontium Ranelate Based Therapiesmentioning
confidence: 99%
“…Strontium (Sr) is an essential trace element in the human body, which has dual effects of promoting bone formation 10,11 and inhibiting bone resorption. 12,13 Strontium ranelate has been successfully used to treat osteoporosis.…”
Section: Introductionmentioning
confidence: 99%